For PAH (WHO Group 1) to diminish symptoms associated with exercise and to diminish the rate of clinical deterioration in patients transitioning from Flolan® (epoprostenol sodium).
Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.
In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.
You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.
REMISIdtcJUL18
Please see accompanying Full Prescribing Information for Remodulin.
For additional information, visit http://www.remodulin.com or call Customer Service at
This information is provided for an informational purpose and is not intended as treatment advice. Patients should consult a healthcare professional for treatment advice.
Remodulin is a prescription medication used to treat adults with pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. Remodulin can reduce symptoms associated with exercise. Remodulin was studied mainly in patients with NYHA Functional Class II-IV symptoms. It is not known if Remodulin is safe and effective in children.
In people with PAH who need to switch from epoprostenol, Remodulin is approved to slow the worsening of symptoms.
You may report side effects to the FDA at www.fda.gov/MedWatch or call 1-800-FDA-1088.
REMISIdtcJUL18
Please see accompanying Full Prescribing Information for Remodulin.
For additional information, visit http://www.remodulin.com or call Customer Service at
This information is provided for an informational purpose and is not intended as treatment advice. Patients should consult a healthcare professional for treatment advice.